PubVisualPubVisual Book a Demo
Resources Blog About Contact Book a 30-Minute Demo →

Visualizing Real-World Evidence for Payers

Strong real-world evidence often gets missed simply because it’s hard to find.

The short version
  • Real-world evidence has become central to payer conversations. And it’s regularly the least-read part of the submission, not because it’s weak.
  • The real-world data a team already has is usually good enough to make the case on its own. What it needs is a shape a busy reader can follow.
  • We take the real-world evidence that's already approved and turn it into a visual story. Zero new claims, every element mapped to the source data.

Strong real-world evidence often gets missed simply because it’s hard to find. Here's what we found, and what it means for how you build your next story.

01Good evidence, buried well

Real-world evidence has become central to payer conversations. And it’s regularly the least-read part of the submission, not because it’s weak, because it arrives as another dense document.

0%

of the time, physicians read only the abstract of a publication, not the full paper.

0

MLR review covers every version, however many journeys one approved core holds.

0+

languages one approved core is produced in, without restarting the scientific review each time.

Every figure here is independently sourced.

02The data isn’t the problem

The real-world data a team already has is usually good enough to make the case on its own. What it needs is a format that gets a payer to the result fast, without making her hunt through methodology sections.

“What it needs is a format that gets a payer to the result fast, without making her hunt through methodology sections.”

03What visualization actually changes

We take the real-world evidence that's already approved and turn it into a visual story. Zero new claims created, every element maps to the source data exactly as filed.

04Depth without five different decks

A pharmacy director wants the budget impact angle. A medical director wants the comparative outcomes. One approved evidence base can let each reader go to the depth their role requires, still covered by a single MLR review.

The Impact Gap ReportFree · request access
Request the report →
Written by
The PubVisual Team
Editorial · PubVisual

We build the science communication our own field teams would want to use, then hand it to yours. This post came out of that same process.

More from the blog →
The Science of Engagement

Let her steer, from the same approved core

PubVisual Engage turns your real-world evidence into a value story payers can actually navigate, no new claims, just clarity.

Questions

Frequently asked questions

Usually because it arrives as another dense document. The data a team already has is often good enough to make the case on its own; what it needs is a shape a busy reader can follow.

No. We take the real-world evidence that's already approved and turn it into a visual story. Zero new claims created, every element mapped to the source data exactly as filed.

One evidence base is enough. The pharmacy director goes to the budget impact angle, the medical director to the comparative outcomes, each at the depth their role requires, all covered by a single MLR review.